Registry update — unassessed
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
Trial registry update: RECRUITING. No results reported in the supplied registry record.
RCTMinor significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 24, 2026 · Discovered: Sep 25, 2026 · Assessed: — · Research update
What it does not prove
- No results are reported, so efficacy of exercise on immunosenescence, relapse rates, or patient outcomes cannot be assessed from this source
- The abstract expresses prospective expectations rather than actual findings, making it impossible to determine what the study actually demonstrated
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- 36 months
- Population
- Patients with oral/head and neck cancer after surgery
- Primary outcome
- Immunosenescence amelioration and relapse reduction in head and neck cancer patients
- Effect size
- —
- Significance
- Not reported
- Journal
- Chang Gung Memorial Hospital
- Published
- Sep 24, 2026
Sources
Primary source
- Chang Gung Memorial Hospital ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery.
The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.